Works matching AU Kobayashi, Kazufumi

Results: 44
    1
    2

    Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage‐associated molecular pattern analysis.

    Published in:
    Hepatology Research, 2025, v. 55, n. 2, p. 291, doi. 10.1111/hepr.14088
    By:
    • Ozaki, Tomomi;
    • Yumita, Sae;
    • Ogasawara, Sadahisa;
    • Fujiya, Makoto;
    • Tsuchiya, Takahiro;
    • Yoshino, Ryohei;
    • Sawada, Midori;
    • Akatsuka, Teppei;
    • Izai, Ryo;
    • Miwa, Chihiro;
    • Yonemoto, Takuya;
    • Fujimoto, Kentaro;
    • Unozawa, Hidemi;
    • Fujiwara, Kisako;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Nakamura, Masato
    Publication type:
    Article
    3

    Carbon‐ion radiotherapy versus radiofrequency ablation as initial treatment for early‐stage hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2022, v. 52, n. 12, p. 1060, doi. 10.1111/hepr.13827
    By:
    • Fujita, Naoto;
    • Kanogawa, Naoya;
    • Makishima, Hirokazu;
    • Ogasawara, Sadahisa;
    • Maruta, Susumu;
    • Iino, Yotaro;
    • Shiko, Yuki;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Wakatsuki, Masaru;
    • Itobayashi, Ei;
    • Obu, Masamichi;
    • Koma, Yoshihiro;
    • Azemoto, Ryosaku
    Publication type:
    Article
    4
    5

    EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-00889-0
    By:
    • Kusakabe, Yuko;
    • Chiba, Tetsuhiro;
    • Oshima, Motohiko;
    • Koide, Shuhei;
    • Rizq, Ola;
    • Aoyama, Kazumasa;
    • Ao, Junjie;
    • Kaneko, Tatsuya;
    • Kanzaki, Hiroaki;
    • Kanayama, Kengo;
    • Maeda, Takahiro;
    • Saito, Tomoko;
    • Nakagawa, Ryo;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Ogasawara, Sadahisa;
    • Suzuki, Eiichiro;
    • Nakamoto, Shingo;
    • Yasui, Shin
    Publication type:
    Article
    6

    Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma.

    Published in:
    BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02674-x
    By:
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Maruta, Susumu;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Yumita, Sae;
    • Iwanaga, Terunao;
    • Unozawa, Hidemi;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Sakuma, Takafumi;
    • Fujita, Naoto;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kobayashi, Kazufumi;
    • Inoue, Masanori;
    • Kiyono, Soichiro
    Publication type:
    Article
    7

    Switching to systemic therapy after locoregional treatment failure: Definition and best timing.

    Published in:
    Clinical & Molecular Hepatology, 2020, v. 26, n. 2, p. 155, doi. 10.3350/cmh.2019.0021n
    By:
    • Sadahisa Ogasawara;
    • Yoshihiko Ooka;
    • Keisuke Koroki;
    • Susumu Maruta;
    • Hiroaki Kanzaki;
    • Kengo Kanayama;
    • Kazufumi Kobayashi;
    • Soichiro Kiyono;
    • Masato Nakamura;
    • Naoya Kanogawa;
    • Tomoko Saito;
    • Takayuki Kondo;
    • Eiichiro Suzuki;
    • Shingo Nakamoto;
    • Akinobu Tawada;
    • Tetsuhiro Chiba;
    • Makoto Arai;
    • Jun Kato;
    • Naoya Kato
    Publication type:
    Article
    8
    9
    10

    The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84117-9
    By:
    • Kanzaki, Hiroaki;
    • Chiba, Tetsuhiro;
    • Ao, Junjie;
    • Koroki, Keisuke;
    • Kanayama, Kengo;
    • Maruta, Susumu;
    • Maeda, Takahiro;
    • Kusakabe, Yuko;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Saito, Tomoko;
    • Nakagawa, Ryo;
    • Ogasawara, Sadahisa;
    • Suzuki, Eiichiro;
    • Ooka, Yoshihiko;
    • Muroyama, Ryosuke;
    • Nakamoto, Shingo
    Publication type:
    Article
    11
    12

    Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus.

    Published in:
    International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 12015, doi. 10.3390/ijms231912015
    By:
    • Ma, Yaojia;
    • Nakamoto, Shingo;
    • Ao, Junjie;
    • Qiang, Na;
    • Kogure, Tadayoshi;
    • Ogawa, Keita;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Iwanaga, Terunao;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Nakagawa, Ryo;
    • Ogasawara, Sadahisa;
    • Muroyama, Ryosuke
    Publication type:
    Article
    13
    14

    Skeletal Muscle Volume Is an Independent Predictor of Survival after Sorafenib Treatment Failure for Hepatocellular Carcinoma.

    Published in:
    Cancers, 2021, v. 13, n. 9, p. 2247, doi. 10.3390/cancers13092247
    By:
    • Saeki, Issei;
    • Yamasaki, Takahiro;
    • Yamauchi, Yurika;
    • Takami, Taro;
    • Kawaoka, Tomokazu;
    • Uchikawa, Shinsuke;
    • Hiramatsu, Akira;
    • Aikata, Hiroshi;
    • Kawano, Reo;
    • Kobayashi, Kazufumi;
    • Kondo, Takayuki;
    • Ogasawara, Sadahisa;
    • Chiba, Tetsuhiro;
    • Chayama, Kazuaki;
    • Kato, Naoya;
    • Sakaida, Isao;
    • Vitale, Alessandro;
    • Lai, Quirino;
    • Geller, David A.
    Publication type:
    Article
    15

    Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment.

    Published in:
    JGH Open, 2021, v. 5, n. 11, p. 1266, doi. 10.1002/jgh3.12660
    By:
    • Mukai, Shohei;
    • Kanzaki, Hiroaki;
    • Ogasawara, Sadahisa;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Unozawa, Hidemi;
    • Iwanaga, Terunao;
    • Sakuma, Takafumi;
    • Fujita, Naoto;
    • Koroki, Keisuke;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Saito, Tomoko;
    • Nakagawa, Ryo;
    • Suzuki, Eiichiro
    Publication type:
    Article
    16

    Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma.

    Published in:
    JGH Open, 2021, v. 5, n. 2, p. 273, doi. 10.1002/jgh3.12483
    By:
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Ooka, Yoshihiko;
    • Inoue, Masanori;
    • Wakamatsu, Toru;
    • Yokoyama, Masayuki;
    • Maruta, Susumu;
    • Unozawa, Hidemi;
    • Iwanaga, Terunao;
    • Sakuma, Takafumi;
    • Fujita, Naoto;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Maeda, Takahiro;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Saito, Tomoko;
    • Motoyama, Tenyu
    Publication type:
    Article
    17

    Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.

    Published in:
    Journal of Gastroenterology, 2024, v. 59, n. 6, p. 515, doi. 10.1007/s00535-024-02097-9
    By:
    • Fujiwara, Kisako;
    • Kondo, Takayuki;
    • Fujimoto, Kentaro;
    • Yumita, Sae;
    • Ogawa, Keita;
    • Ishino, Takamasa;
    • Nakagawa, Miyuki;
    • Iwanaga, Terunao;
    • Tsuchiya, Satoshi;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Koizumi, Jun
    Publication type:
    Article
    18

    Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents.

    Published in:
    Journal of Gastroenterology, 2022, v. 57, n. 2, p. 90, doi. 10.1007/s00535-021-01837-5
    By:
    • Seko, Yuya;
    • Moriguchi, Michihisa;
    • Takahashi, Aya;
    • Yamaguchi, Kanji;
    • Umemura, Atsushi;
    • Okuda, Keiichiro;
    • Kataoka, Seita;
    • Unozawa, Hidemi;
    • Kobayashi, Kazufumi;
    • Ogasawara, Sadahisa;
    • Sato, Rui;
    • Tsuchiya, Satoshi;
    • Watanabe, Shunji;
    • Morimoto, Naoki;
    • Iwai, Kenji;
    • Aramaki, Takeshi;
    • Kato, Naoya;
    • Itoh, Yoshito
    Publication type:
    Article
    19

    Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study).

    Published in:
    Investigational New Drugs, 2024, v. 42, n. 4, p. 394, doi. 10.1007/s10637-024-01441-3
    By:
    • Kobayashi, Kazufumi;
    • Ogasawara, Sadahisa;
    • Itobayashi, Ei;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Nakamura, Kazuyoshi;
    • Moriguchi, Michihisa;
    • Watanabe, Shunji;
    • Ikeda, Masafumi;
    • Kuroda, Hidekatsu;
    • Kawaoka, Tomokazu;
    • Hiraoka, Atsushi;
    • Yasui, Yutaka;
    • Kuzuya, Teiji;
    • Sato, Rui;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Nakamura, Masato;
    • Kiyono, Soichiro
    Publication type:
    Article
    20

    Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan.

    Published in:
    Investigational New Drugs, 2020, v. 38, n. 1, p. 172, doi. 10.1007/s10637-019-00801-8
    By:
    • Ogasawara, Sadahisa;
    • Ooka, Yoshihiko;
    • Itokawa, Norio;
    • Inoue, Masanori;
    • Okabe, Shinichiro;
    • Seki, Atsuyoshi;
    • Haga, Yuki;
    • Obu, Masamichi;
    • Atsukawa, Masanori;
    • Itobayashi, Ei;
    • Mizumoto, Hideaki;
    • Sugiura, Nobuyuki;
    • Azemoto, Ryosaku;
    • Kanayama, Kengo;
    • Kanzaki, Hiroaki;
    • Maruta, Susumu;
    • Maeda, Takahiro;
    • Kusakabe, Yuko;
    • Yokoyama, Masayuki;
    • Kobayashi, Kazufumi
    Publication type:
    Article
    21

    Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment.

    Published in:
    Investigational New Drugs, 2018, v. 36, n. 2, p. 332, doi. 10.1007/s10637-017-0507-3
    By:
    • Sadahisa Ogasawara;
    • Tetsuhiro Chiba;
    • Yoshihiko Ooka;
    • Eiichiro Suzuki;
    • Takahiro Maeda;
    • Masayuki Yokoyama;
    • Toru Wakamatsu;
    • Masanori Inoue;
    • Tomoko Saito;
    • Kazufumi Kobayashi;
    • Soichiro Kiyono;
    • Masato Nakamura;
    • Shingo Nakamoto;
    • Shin Yasui;
    • Akinobu Tawada;
    • Makoto Arai;
    • Tatsuo Kanda;
    • Hitoshi Maruyama;
    • Osamu Yokosuka;
    • Naoya Kato
    Publication type:
    Article
    22
    23
    24

    The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-25350-8
    By:
    • Kondo, Takayuki;
    • Fujiwara, Kisako;
    • Nakagawa, Miyuki;
    • Unozawa, Hidemi;
    • Iwanaga, Terunao;
    • Sakuma, Takafumi;
    • Fujita, Naoto;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Saito, Tomoko;
    • Ogasawara, Sadahisa;
    • Suzuki, Eiichiro;
    • Ooka, Yoshihiko;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Arai, Makoto
    Publication type:
    Article
    25

    Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular Carcinoma.

    Published in:
    Case Reports in Oncology, 2021, v. 14, n. 2, p. 1103, doi. 10.1159/000517440
    By:
    • Yoshida, Ryoi;
    • Koroki, Keisuke;
    • Makishima, Hirokazu;
    • Ogasawara, Sadahisa;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Unozawa, Hidemi;
    • Iwanaga, Terunao;
    • Fujita, Naoto;
    • Sakuma, Takafumi;
    • Kanzaki, Hiroaki;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Saito, Tomoko;
    • Nakagawa, Ryo
    Publication type:
    Article
    26
    27

    Selective instance segmentation for pose estimation.

    Published in:
    Advanced Robotics, 2022, v. 36, n. 17/18, p. 890, doi. 10.1080/01691864.2022.2104621
    By:
    • Matsumoto, Kazuhisa;
    • Ibuki, Yusuke;
    • Tomikawa, Ryusei;
    • Kobayashi, Kazufumi;
    • Ohara, Kenichi;
    • Tasaki, Tsuyoshi
    Publication type:
    Article
    28

    Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma.

    Published in:
    PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0261619
    By:
    • Kondo, Takayuki;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Saito, Tomoko;
    • Ogasawara, Sadahisa;
    • Ooka, Yoshihiko;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Arai, Makoto;
    • Kato, Jun;
    • Kuboki, Satoshi;
    • Ohtsuka, Masayuki;
    • Kato, Naoya
    Publication type:
    Article
    29

    Changes in therapeutic options for hepatocellular carcinoma in Asia.

    Published in:
    Liver International, 2022, v. 42, n. 9, p. 2055, doi. 10.1111/liv.15101
    By:
    • Sadahisa Ogasawara;
    • Keisuke Koroki;
    • Hiroaki Kanzaki;
    • Kazufumi Kobayashi;
    • Soichiro Kiyono;
    • Masato Nakamura;
    • Naoya Kanogawa;
    • Tomoko Saito;
    • Takayuki Kondo;
    • Ryo Nakagawa;
    • Shingo Nakamoto;
    • Ryosuke Muroyama;
    • Tetsuhiro Chiba;
    • Naoya Kato
    Publication type:
    Article
    30

    Changes in therapeutic options for hepatocellular carcinoma in Asia.

    Published in:
    Liver International, 2022, v. 42, n. 8, p. 2055, doi. 10.1111/liv.15101
    By:
    • Ogasawara, Sadahisa;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Saito, Tomoko;
    • Kondo, Takayuki;
    • Nakagawa, Ryo;
    • Nakamoto, Shingo;
    • Muroyama, Ryosuke;
    • Chiba, Tetsuhiro;
    • Kato, Naoya
    Publication type:
    Article
    31

    Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysis.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1459, doi. 10.1007/s10147-022-02195-9
    By:
    • Ozeki, Yusuke;
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Ogawa, Keita;
    • Ishino, Takamasa;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Unozawa, Hidemi;
    • Iwanaga, Terunao;
    • Sakuma, Takafumi;
    • Fujita, Naoto;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kobayashi, Kazufumi;
    • Nakamura, Masato;
    • Kiyono, Soichiro;
    • Kondo, Takayuki;
    • Saito, Tomoko;
    • Nakagawa, Ryo
    Publication type:
    Article
    32

    Comprehensive Analysis of Radiologic Cancer-Free Status through Various Treatment Approaches in Advanced-Stage Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 286, doi. 10.1159/000542577
    By:
    • Koroki, Keisuke;
    • Ogasawara, Sadahisa;
    • Izai, Ryo;
    • Yonemoto, Takuya;
    • Akatsuka, Teppei;
    • Miwa, Chihiro;
    • Yumita, Sae;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Nakada, Shinichiro;
    • Sakai, Nozomu;
    • Yokoyama, Masayuki;
    • Ohtsuka, Masayuki;
    • Kato, Naoya
    Publication type:
    Article
    33

    Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy.

    Published in:
    Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 8, doi. 10.1159/000539380
    By:
    • Inoue, Masanori;
    • Ogasawara, Sadahisa;
    • Kobayashi, Kazufumi;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Obu, Masamichi;
    • Fujimoto, Kentaro;
    • Unozawa, Hidemi;
    • Yumita, Sae;
    • Fujiwara, Kisako;
    • Nakagawa, Miyuki;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Nagashima, Kengo;
    • Itobayashi, Ei
    Publication type:
    Article
    34

    Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 4, p. 329, doi. 10.1159/000522389
    By:
    • Yamasaki, Takahiro;
    • Saeki, Issei;
    • Yamauchi, Yurika;
    • Matsumoto, Toshihiko;
    • Suehiro, Yutaka;
    • Kawaoka, Tomokazu;
    • Uchikawa, Shinsuke;
    • Hiramatsu, Akira;
    • Aikata, Hiroshi;
    • Kobayashi, Kazufumi;
    • Kondo, Takayuki;
    • Ogasawara, Sadahisa;
    • Chiba, Tetsuhiro;
    • Takami, Taro;
    • Chayama, Kazuaki;
    • Kato, Naoya;
    • Sakaida, Isao
    Publication type:
    Article
    35

    Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 48, doi. 10.1159/000519868
    By:
    • Kobayashi, Kazufumi;
    • Ogasawara, Sadahisa;
    • Takahashi, Aya;
    • Seko, Yuya;
    • Unozawa, Hidemi;
    • Sato, Rui;
    • Watanabe, Shunji;
    • Moriguchi, Michihisa;
    • Morimoto, Naoki;
    • Tsuchiya, Satoshi;
    • Iwai, Kenji;
    • Inoue, Masanori;
    • Ogawa, Keita;
    • Ishino, Takamasa;
    • Iwanaga, Terunao;
    • Sakuma, Takafumi;
    • Fujita, Naoto;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Nakamura, Masato
    Publication type:
    Article
    36

    Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials.

    Published in:
    Liver Cancer (2235-1795), 2020, v. 9, n. 5, p. 596, doi. 10.1159/000508809
    By:
    • Koroki, Keisuke;
    • Ogasawara, Sadahisa;
    • Ooka, Yoshihiko;
    • Kanzaki, Hiroaki;
    • Kanayama, Kengo;
    • Maruta, Susumu;
    • Maeda, Takahiro;
    • Yokoyama, Masayuki;
    • Wakamatsu, Toru;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Saito, Tomoko;
    • Kondo, Takayuki;
    • Suzuki, Eiichiro;
    • Nakamoto, Shingo;
    • Yasui, Shin;
    • Tawada, Akinobu
    Publication type:
    Article
    37

    Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2020, v. 9, n. 4, p. 382, doi. 10.1159/000507022
    By:
    • Maruta, Susumu;
    • Ogasawara, Sadahisa;
    • Ooka, Yoshihiko;
    • Obu, Masamichi;
    • Inoue, Masanori;
    • Itokawa, Norio;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Okabe, Shinichiro;
    • Azemoto, Ryosaku;
    • Itobayashi, Ei;
    • Atsukawa, Masanori;
    • Sugiura, Nobuyuki;
    • Mizumoto, Hideaki;
    • Koroki, Keisuke;
    • Kanayama, Kengo;
    • Kanzaki, Hiroaki;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato
    Publication type:
    Article
    38
    39

    Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis.

    Published in:
    Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 513, doi. 10.1007/s40801-023-00379-x
    By:
    • Kanzaki, Hiroaki;
    • Ogasawara, Sadahisa;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Yoshino, Ryohei;
    • Fujimoto, Kentaro;
    • Kogure, Tadayoshi;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Iwanaga, Terunao;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Kojima, Ryuta;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato
    Publication type:
    Article
    40

    Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41425-6
    By:
    • Kondo, Takayuki;
    • Fujimoto, Kentaro;
    • Fujiwara, Kisako;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Nakagawa, Miyuki;
    • Iwanaga, Terunao;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Kato, Jun;
    • Fujiwara, Keiichi
    Publication type:
    Article
    41

    Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41425-6
    By:
    • Kondo, Takayuki;
    • Fujimoto, Kentaro;
    • Fujiwara, Kisako;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Nakagawa, Miyuki;
    • Iwanaga, Terunao;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Kato, Jun;
    • Fujiwara, Keiichi
    Publication type:
    Article
    42

    Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38377-2
    By:
    • Kondo, Takayuki;
    • Fujiwara, Kisako;
    • Nakagawa, Miyuki;
    • Fujimoto, Kentaro;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Iwanaga, Terunao;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Kato, Jun;
    • Kato, Naoya
    Publication type:
    Article
    43

    Percutaneous Two-Dimensional Shear Wave Elastography for Diagnosis of Pancreatic Tumor.

    Published in:
    Diagnostics (2075-4418), 2021, v. 11, n. 3, p. 498, doi. 10.3390/diagnostics11030498
    By:
    • Iino, Yotaro;
    • Maruyama, Hitoshi;
    • Mikata, Rintaro;
    • Yasui, Shin;
    • Koroki, Keisuke;
    • Nagashima, Hiroki;
    • Awatsu, Masami;
    • Shingyoji, Ayako;
    • Kusakabe, Yuko;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Ohyama, Hiroshi;
    • Sugiyama, Harutoshi;
    • Sakai, Yuji;
    • Chiba, Tetsuhiro;
    • Kato, Jun;
    • Tsuyuguchi, Toshio;
    • Kato, Naoya;
    • Alongi, Pierpaolo
    Publication type:
    Article
    44